Skip to main content
WoMWeb of Medicine
SearchGraphHistory
pulmonology›Clinical Question·Updated Jul 4, 2026·v1

empiric antibiotic therapy for community-acquired pneumonia [Grok-4.3]

The referenced guidelines do not address empiric antibiotic therapy for community-acquired pneumonia. [1] recommends that the overall peritonitis rate should be no more than 0.40 episodes per year at risk and the percentage of patients free of peritonitis per unit time should be targeted at

Moderate Evidence14 references·565 words·3 min read·v1
The referenced guidelines do not address empiric antibiotic therapy for community-acquired pneumonia. [1] recommends that the overall peritonitis rate should be no more than 0.40 episodes per year at risk and the percentage of patients free of peritonitis per unit time should be targeted at >80% per year, along with updated recommendations regarding empirical antibiotic selection.

Board Review — High Yield

  • •No relevant evidence on empiric antibiotic therapy for community-acquired pneumonia appears in the supplied references
  • •No historical evolution data or landmark trials on empiric antibiotics for community-acquired pneumonia are present in references [3-10]
  • •No pivotal trials or effect sizes on the topic are present in references [3-14]
  • •Provided references contain no data on community-acquired pneumonia or antibiotic therapy, precluding assessment of applicability or caveats.
  • •No relevant post-guideline evidence or ongoing trials appear in the provided abstracts

Deep Dive — Evidence Details

References

  1. [1]

    Li PK, Chow KM, Cho Y et al.. “ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment.” Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2022). PMID: 35264029 ↗

    L2GUIDELINECited in: Bottom Line
  2. [2]

    da Silva JSV, Seres DS, Sabino K et al.. “ASPEN Consensus Recommendations for Refeeding Syndrome.” Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition (2020). PMID: 32115791 ↗

    L5REVIEW_NARRATIVECited in: Bottom Line
  3. [3]

    Sejersen T, Kroksmark AK, Törnblom A et al.. “Disease progression and economic burden of duchenne muscular dystrophy: A retrospective study using Swedish register data.” Journal of neuromuscular diseases (2026). PMID: 42400353 ↗

    L3COHORTCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  4. [4]

    Hashimoto Y, Yoshida M, Miyagi T et al.. “Association between GLIM-defined malnutrition and in-hospital costs in adults with sepsis: A sub analysis of a prospective cohort study.” JPEN. Journal of parenteral and enteral nutrition (2026). PMID: 42400337 ↗

    L3COHORTCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  5. [5]

    Pancini E, Cremaschi G, Degani M et al.. “Savor-Aging: The Art of Savoring Positive Emotions in Older Adulthood-A Randomized Controlled Trial.” Applied psychology. Health and well-being (2026). PMID: 42400304 ↗

    L1RCTCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  6. [6]

    Sakai A, Sugiyama M, Onodera M et al.. “Adeno-Associated Virus Gene Therapy for Spinal Muscular Atrophy Induces Hepatotoxicity via Cytokine and Macrophage Activation.” Liver international : official journal of the International Association for the Study of the Liver (2026). PMID: 42400303 ↗

    L4CASE_REPORTCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  7. [7]

    Li Y, Wen J, Cao X et al.. “Small Extracellular Vesicle-TLN1 Modulates Gastric Cancer Cells and Remodels Lymphatic Endothelial Cells Through AKT Activation to Potentiate Lymphatic Metastasis.” Cell biology international (2026). PMID: 42400362 ↗

    L5OTHERCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  8. [8]

    Pasanen N, Talala K, Remmers S et al.. “Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).” BJU international (2026). PMID: 42400346 ↗

    L5OTHERCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  9. [9]

    Pastukh V, Zhang J, Alexander PG et al.. “Repurposing Metformin to Promote Fracture Callus Maturation via AMPK-Driven Metabolic Activation.” Journal of orthopaedic research : official publication of the Orthopaedic Research Society (2026). PMID: 42400344 ↗

    L5OTHERCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  10. [10]

    Ichimasa K, Kudo SE, Kouyama Y et al.. “Competing Mortality Redefines the Net Benefit of Additional Surgery After Endoscopic Resection for T1 Colorectal Cancer in Older Adults.” Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society (2026). PMID: 42400343 ↗

    L5REVIEW_NARRATIVECited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  11. [11]

    Spano L, Bourdon C, Lajnef M et al.. “Epigenetic Age Accelerations and the Clinical Presentation of Bipolar Disorders: A Latent Profile Analysis in the FACE-BD Sample.” Bipolar disorders (2026). PMID: 42400340 ↗

    L5OTHERCited in: Bottom Line, Current Evidence and Standard, Applicability and Caveats
  12. [12]

    Tarasov G, Cohen R, Warshawski S et al.. “Couples' optimism, stress, and quality of life when undergoing fertility treatments: A cross-sectional study with prospective outcome assessment.” Women's health (London, England) (2026). PMID: 42400338 ↗

    L5OTHERCited in: Bottom Line, Current Evidence and Standard, Applicability and Caveats
  13. [13]

    Knaak S, Reichert OS, Ameyaw S et al.. “Supporting Physician Well-being and Mental Health Clinical Skill Development: Evaluation of Mental Health Skills Groups for Physicians.” Healthcare management forum (2026). PMID: 42400336 ↗

    L5OTHERCited in: Current Evidence and Standard
  14. [14]

    Ge H, Fang F, Wan R et al.. “Genome-Wide Identification and Functional Characterization of Dof Transcription Factors Involved in Salt Stress Responses in Taraxacum kok-saghyz.” Physiologia plantarum (2026). PMID: 42400331 ↗

    L5OTHERCited in: Current Evidence and Standard

Revision History

All updates applied to this page

Loading revisions…